BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer (BASE HSP110)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02458664|
Recruitment Status : Unknown
Verified November 2015 by Assistance Publique - Hôpitaux de Paris.
Recruitment status was: Active, not recruiting
First Posted : June 1, 2015
Last Update Posted : December 2, 2015
We collect prospectively and retrospectively, patients' demographic, pathological, surgical, therapeutic and prognosis informations in a database. After patient's consent to collect tumoural samples of their colorectal cancer after resection.
We will then be able to evaluate the impact of HSP110, a chaperon protein, on their prognosis. Other proteins (to be determined) will also be study, after.
|Condition or disease||Intervention/treatment|
|Rectum Cancer Cancer of Colon||Genetic: Genetic analysis on tumor kept in tumor bank|
|Study Type :||Observational|
|Actual Enrollment :||597 participants|
|Official Title:||BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer|
|Study Start Date :||November 2013|
|Estimated Primary Completion Date :||November 2018|
|Estimated Study Completion Date :||November 2018|
All patients undergoing curative colorectal cancer in general and digestive surgery department at Saint-Antoine hospital
Genetic: Genetic analysis on tumor kept in tumor bank
- Recurrence free survival and Recurrence free survival after resection of the colon cancer [ Time Frame: End of follow up : at least 3 years ]3 years for prospective patients, more for retrospective patients
- Overall survival [ Time Frame: End of follow up : at least 3 years ]3 years for prospective patients, more for retrospective patients
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02458664
|Department of Digestive Surgery, Hôpital Saint-Antoine|
|Paris, France, 75012|